Brightgene Bio-Medical Technology Co.,Ltd. Stock Forum

Despite high P/E ratio and slower growth, investors hope for a business turnaround. However, if P/E aligns with recent growth rates, shareholders may face disappointment. Weak earnings and slower market growth suggest share price risk, posing significant risk to shareholders and potential investors.

With shrinking earnings and below market growth rates, it's hard to justify the high P/E ratio. Absent swift medium-term improvements, shares might drop and with it the P/E ratio. Current soaring prices may be risky, posing potential threats to investors.